Home>News & Events>Publications>C-Path>Global Efforts to Accelerate the Development of Safe and Efficacious Therapies for Newborns11144
September 13, 2015 PRINT PDF
Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy
Challenges and Opportunities to Enhance Global Drug Development in Neonates
Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (including Biological Products) in Neonates
The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates
CPTR’s Relational Sequencing TB Data Platform (ReSeqTB) is highlighted on pages 59 and 60 of UNITAID’s “2015 Tuberculosis Diagnostics Technology and Market Landscape” report.